Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

Abstract

Biomarkers have permitted to estimate prevalence of advanced fibrosis around 2.8% in a general population aged 40 years or older, and several risk factors which may be used for the validation of selective or non-selective screening strategies.